Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

5
Biotech Movers and Shakers for July 16

16h biospace
With the Independence Day holiday in the rearview mirror, numerous biopharma companies continued to adjust their leadership ranks and strengthen the members of various boards representing and overseeing the companies.
XKE DFFN JUNO FMI RESX ALRN

2
Funky Leverage At Funko

2018-07-15 seekingalpha
The company's shares have doubled in just three months, and it's not hard to see why.
XKE FNKO WMT

0
Five Below to Open Flagship Store on NYC’s Fifth Avenue

2018-07-13 investorplace
Five Below (NASDAQ:FIVE) announced that the company would be opening a flagship store on New York City’s Fifth Avenue sometime later this year.
XKE FIVE

45
Taking Stock Of The State Of Retail

2018-07-13 seekingalpha
Joseph Harry, author of Harry’s Retail Report on Marketplace, believes brick and mortar is here to stay, especially perishables and off-price purveyors.
TJX XKE TGT AMZN SWGNF SWGAY SWGAF DG MSFT WMT HSY ROST

1
Wendy Silverstein Plans Exit From New York REIT - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VNO.PRH VNO.PRK VNO.PRL XKE VNO.PRF VNO.PRICL VNO.PRM BPY VNO VNO.WI VNORP CXP TRTX NYRT VNO.PRG VNO.PRI

27
10 Fast-Growing Stocks With Monster Catalysts This Summer | InvestorPlace

2018-07-11 investorplace
We’re now officially into the dog days of summer… a time of year that’s not just painfully hot outdoors, but notoriously slow for stocks. On average, the S&P 500 goes nowhere between mid-July and mid-October.
HON FB XKE DATA NBIX NYTAB NVDA SNEJF EXPE TGT HON ROKU SNE DXC.WI DXC

138
3 Attractive Yields And 3 That Are Overpriced

2018-07-11 seekingalpha
We are starting to see some bifurcation in the high dividend stocks depending on the sector.
XKE ARCC RAD LB ARDC

1
ACSI survey chick-fil-a, texas roadhouse top fast-food, full-service restaurants

2018-07-10 cnbc
When it comes to their favorite fast-food chain, consumers keep clucking about Chick-fil-A, a new survey finds.
XKE TXRH

15
Cramer Remix: Hasbro is the Nike of the toy space

2018-07-09 cnbc
It's time for investors to reconsider the stock of toymaker Hasbro after retailer Toys R Us closed the last of its U.S. stores, CNBC's Jim Cramer said on Monday.
WFCNP XKE MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG SFIX MS.PRA WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN SEDG WFC.PRY MS WFC.PRX FSLR WFC.PRW WFC.PRV WFC WFC.WS MS.PRI MS.PRK

0
Cramer: Use Toys R Us-related weakness to scale into Hasbro's stock

2018-07-09 cnbc
It's time for investors to reconsider the stock of toymaker Hasbro after retailer Toys R Us closed the last of its U.S. stores, CNBC's Jim Cramer said on Monday.
XKE

43
Amazon Creating New & Improved Toys R Us in Order to Boost Prime

2018-07-07 investorplace
Remember when Amazon.com, Inc. (NASDAQ:AMZN) catalyzed the retail apocalypse? Remember when they raised eyebrows during that stretch when they built their own physical book stores? Better yet, remember when they shocked the world by acquiring Whole Foods Market, a physical grocer that didn’t seem to fit Amazon’s digital retail model?
WFM XKE AMZN

39
Amazon Toy Catalog? Retailer Considers Mailing Millions This Holiday

2018-07-05 investorplace
Amazon (NASDAQ:AMZN) is looking to take over where Toys R Us left off this holiday season.
XKE TGT AMZN WMT

10
Five Below - Strong Growth But Major Headwinds On The Horizon

2018-07-05 seekingalpha
While quarterly results and guidance were solid, the stock overreacted, and valuation is now extremely stretched.
XKE TGT DKS KSS TRI BKS FIVE WMT BBBY

3
Toys R Us closes, leaving nostalgia, anger and a chance of revival

2018-07-02 cnbc
Toys R Us shuttered its doors in the U.S. on Friday, leaving in its wake a great deal of sadness, pockets of anger and some slim hope.
VNO.PRH VNO.PRK VNO.PRL XKE VNO.PRF VNO.PRM VNO.PRICL VNO VNO.WI VNORP VNO.PRG VNO.PRI

50
The #1 Retail REIT Best Prepared To Battle Amazon

2018-07-02 seekingalpha
AMZN proved what most REIT management teams have been saying for some time, that successful retailers have to pursue an Omni-channel strategy and real estate is key.
REG BRK.A REG.PRG SVU XKE REG.PRF KR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

48m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 21988G619